TABLE 1

Clinical characteristics

CaseAge at transplant (years)SexDiagnosisDonor sexSurvival (days)
135MaleCGLFemale90
229MaleMDSFemale46
339MaleMyelomaFemale1,235
440FemaleAAMale13
520FemaleAAMale59
635FemaleAMLMale146
750FemaleMyelomaMale27
857FemaleMDSMale116
9*13MaleAAFemale29
1026MaleAMLFemale459
1129MaleMDSFemale78
1245MaleAMLFemale21
1330FemaleAMFMale90
1441FemaleMDSMale204
1543MaleMDSFemale136
1633FemaleCGLMale41
1733FemaleAMLMale25
1835FemaleAMLMale13
1944MaleMyelomaFemale24
2028FemaleCGLMale24
2139MaleMDSFemale1,171
2216MaleAMLFemale51
2344MaleALLFemale230
2442FemalePLLMale964
2533FemaleALLMale94
2645MaleAMLFemale131
2748MaleAMLFemale103
2835FemaleNHLMale88
2953MaleAMLFemale54
3053MaleNHLFemale39
3142MaleAMLFemale23
  • *

    * Type 2 diabetes;

  • impaired fasting glucose. AA, aplastic anemia; ALL, acute lymphocytic leukemia; AMF, acute myelofibrosis; AML, acute myeloid leukemia; CGL, chronic granulocytic leukemia; MDS, myelodisplastic syndrome; NHL, non-Hodgkin's lymphoma; PLL, prolymphocytic leukemia.